Evaluation of serum cardiac troponin I concentration in Boxers with arrhythmogenic right ventricular cardiomyopathy

Ryan D. Baumwart Department of Veterinary Clinical Sciences, College of Veterinary Medicine, The Ohio State University, Columbus, OH 43210.

Search for other papers by Ryan D. Baumwart in
Current site
Google Scholar
PubMed
Close
 DVM
,
João Orvalho Department of Veterinary Clinical Sciences, College of Veterinary Medicine, The Ohio State University, Columbus, OH 43210.

Search for other papers by João Orvalho in
Current site
Google Scholar
PubMed
Close
 DVM
, and
Kathryn M. Meurs Department of Veterinary Clinical Sciences, College of Veterinary Medicine, The Ohio State University, Columbus, OH 43210.

Search for other papers by Kathryn M. Meurs in
Current site
Google Scholar
PubMed
Close
 DVM, PhD

Abstract

Objective—To evaluate serum cardiac troponin I (cTnI) concentrations in Boxers with arrhythmogenic right ventricular cardiomyopathy (ARVC), unaffected (control) Boxers, and control non-Boxers.

Animals—10 Boxers with a clinical diagnosis of ARVC defined by ≥ 1,000 ventricular premature complexes (VPCs)/24 h on an ambulatory ECG, 10 control Boxers assessed as normal by the presence of < 5 VPCs/24h, and 10 control non-Boxers.

Procedures—Serum was extracted from a blood sample from each dog. Analysis of serum cTnI concentrations was performed.

Results—Mean ± SD serum cTnI concentration was 0.142 ± 0.05 ng/mL for Boxers with ARVC, 0.079 ± 0.03 ng/mL for control Boxers, and 0.023 ± 0.01 ng/mL for control non-Boxers. A significant difference in serum cTnI concentrations was observed among the 3 groups. In the combined Boxer population (ie, Boxers with ARVC and control Boxers), a significant correlation was found between serum cTnI concentration and number of VPCs/24 h (r = 0.78) and between serum cTnI concentration and grade of ventricular arrhythmia (r = 0.77).

Conclusions and Clinical Relevance—Compared with clinically normal dogs, Boxers with ARVC had a significant increase in serum cTnI concentration. For Boxers, correlations were found between serum cTnI concentration and number of VPCs/24 h and between concentration and the grade of arrhythmia. Because of the overlap in serum cTnI concentrations in control Boxers and Boxers with ARVC, future studies should evaluate the correlation of serum cTnI concentration with severity of disease in terms of degree of myocardial fibrofatty changes.

Abstract

Objective—To evaluate serum cardiac troponin I (cTnI) concentrations in Boxers with arrhythmogenic right ventricular cardiomyopathy (ARVC), unaffected (control) Boxers, and control non-Boxers.

Animals—10 Boxers with a clinical diagnosis of ARVC defined by ≥ 1,000 ventricular premature complexes (VPCs)/24 h on an ambulatory ECG, 10 control Boxers assessed as normal by the presence of < 5 VPCs/24h, and 10 control non-Boxers.

Procedures—Serum was extracted from a blood sample from each dog. Analysis of serum cTnI concentrations was performed.

Results—Mean ± SD serum cTnI concentration was 0.142 ± 0.05 ng/mL for Boxers with ARVC, 0.079 ± 0.03 ng/mL for control Boxers, and 0.023 ± 0.01 ng/mL for control non-Boxers. A significant difference in serum cTnI concentrations was observed among the 3 groups. In the combined Boxer population (ie, Boxers with ARVC and control Boxers), a significant correlation was found between serum cTnI concentration and number of VPCs/24 h (r = 0.78) and between serum cTnI concentration and grade of ventricular arrhythmia (r = 0.77).

Conclusions and Clinical Relevance—Compared with clinically normal dogs, Boxers with ARVC had a significant increase in serum cTnI concentration. For Boxers, correlations were found between serum cTnI concentration and number of VPCs/24 h and between concentration and the grade of arrhythmia. Because of the overlap in serum cTnI concentrations in control Boxers and Boxers with ARVC, future studies should evaluate the correlation of serum cTnI concentration with severity of disease in terms of degree of myocardial fibrofatty changes.

  • 1

    Basso C, Fox FR, Meurs KM, et al. Arrhythmogenic right ventricular cardiomyopathy causing sudden cardiac death in boxer dogs: a new animal model of human disease. Circulation 2004;109:11801185.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 2

    Meurs KM, Spier AW, Miller MW, et al. Familial ventricular arrhythmias in boxers. J Vet Intern Med 1999;13:437439.

  • 3

    Harpster N. Boxer cardiomyopathy. In:Kirk RW, ed.Current veterinary therapy VIII. Philadelphia: WB Saunders Co, 1983;329337.

  • 4

    Harpster N. Boxer cardiomyopathy. Vet Clin North Am Small Anim Pract 1991;21:9891004.

  • 5

    Haggstrom J, Hansson K, Kvart C, et al. Relationship between different natriuretic peptides and severity of naturally acquired mitral regurgitation in dogs with chronic myxomatous valve disease. J Vet Cardiol 2000;2:716.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 6

    Asano K, Masuda K, Okumura M, et al. Plasma atrial and brain natriuretic peptide levels in dogs with congestive heart failure. J Vet Med Sci 1999;61:523529.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 7

    MacDonald KA, Kittleson MD, Munro C, et al. Brain natriuretic peptide concentration in dogs with heart disease and congestive heart failure. J Vet Intern Med 2003;17:172177.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 8

    Chetboul V, Tessier-Vetzel D, Escriou C, et al. Diagnostic potential of natriuretic peptides in the occult phase of golden retriever muscular dystrophy cardiomyopathy. J Vet Intern Med 2004;18:845850.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 9

    Prosek R, Sisson D, Oyama M, et al. Plasma endothelin-1 immunoreactivity in normal dogs and dogs with acquired heart disease. J Vet Intern Med 2004;18:840844.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 10

    Rush JE, Lee ND, Freeman LM, et al. C-reactive protein concentration in dogs with chronic valvular disease. J Vet Intern Med 2006;20:635639.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 11

    Baumwart RD, Meurs KM. Assessment of plasma brain natriuretic peptide concentration in Boxers with arrhythmogenic right ventricular cardiomyopathy. Am J Vet Res 2005;66:20862089.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 12

    Wu AH, Feng Y, Moore R, et al. Characterization of cardiac troponin subunit release into serum after acute myocardial infarction and comparison of assays for troponin T and I. Clin Chem 1998;44:11981208.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 13

    Adams JE, Bodor GS, Davila-Roman VG, et al. Cardiac troponin I: a marker with high specificity for cardiac injury. Circulation 1993;88:101106.

  • 14

    Wu AH, Valdes R, Apple FS, et al. Cardiac troponin-T immunoassay for diagnosis of acute myocardial infarction. Clin Chem 1994;40:900907.

  • 15

    Voss EM, Sharkey SW, Gernert AE, et al. Human and canine cardiac troponin T and creatine kinase-MB distribution in normal and diseased myocardium: infact sizing using serum profiles. Arch Pathol Lab Med 1995;119:799806.

    • Search Google Scholar
    • Export Citation
  • 16

    Gallegos RP, Swingen C, Xu XJ, et al. Infarct extent by MRI correlates with peak serum troponin level in the canine model. J Surg Res 2004;120:266271.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 17

    Ricchiuti V, Sharkey SW, Murakami MM, et al. Cardiac troponin I and T alterations in dog hearts with myocardial infarction: correlation with infarct size. Am J Clin Pathol 1998;110:241247.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 18

    Smith SC, Ladenson JH, Mason JW, et al. Elevations of cardiac troponin I associated with myocarditis. Circulation 1997;95:163168.

  • 19

    Lim B, Shin J, Choe S, et al. Myocardial injury occurs earlier than myocardial inflammation in acute experimental viral myocarditis. Exp Mol Med 2005;37:5157.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 20

    Lowbeer C, Gustafsson SA, Seeberger A, et al. Serum cardiac troponin T in patients hospitalized with heart failure is associated with left ventricular hypertrophy and systolic dysfunction. Scand J Clin Invest 2004;64:667676.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 21

    Sato Y, Yamada T, Taniguchi R, et al. Persistently increased serum concentrations of cardiac troponin T in patients with idiopathic dilated cardiomyopathy are predictive of adverse outcomes. Circulation 2001;103:369374.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 22

    Horwich TB, Patel J, MacLellan WR, et al. Cardiac troponin I is associated with impaired hemodynamics, progressive left ventricular dysfunction, and increased mortality rates in advanced heart failure. Circulation 2003;108:833838.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 23

    Missov E, Calzolari C, Pau B. Circulating cardiac troponin I in severe congestive heart failure. Circulation 1997;96:29532958.

  • 24

    Sleeper MM, Clifford CA, Laster LL. Cardiac troponin I in the normal dog and cat. J Vet Intern Med 2001;15:501503.

  • 25

    Adin DB, Milner RJ, Berger KD, et al. Cardiac troponin I concentrations in normal dogs and cats using a bedside analyzer. J Vet Cardiol 2005;7:2732.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 26

    Schober KE, Cornand C, Kirbach B, et al. Serum cardiac troponin I and cardiac troponin T concentrations in dogs with gastric dilatation-volvulus. J Am Vet Med Assoc 2002;221:381388.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 27

    Oyama MA, Sisson DD. Cardiac troponin-I concentration in dogs with cardiac disease. J Vet Intern Med 2004;18:831839.

  • 28

    Lobetti R, Dvir E, Pearson J. Cardiac troponins in canine babesiosis. J Vet Intern Med 2002;16:6368.

  • 29

    Shaw SP, Rozanski EA, Rush JE. Cardiac troponin I and T in dogs with pericardial effusion. J Vet Intern Med 2004;18:322324.

  • 30

    Selting KA, Lana SE, Ogilvie GK, et al. Cardiac troponin I in canine patients with lymphoma and osteosarcoma receiving doxorubicin: comparison with clinical heart disease in a retrospective analysis. Vet Comp Oncol 2004;2:142156.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 31

    Schober KE, Kirbach B, Oechtering G. Noninvasive assessment of myocardial cell injury in dogs with suspected cardiac contusion. J Vet Cardiol 1999;1:1725.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 32

    Spratt DP, Mellanby RJ, Drury N, et al. Cardiac troponin I: evaluation of a biomarker for the diagnosis of heart disease in the dog. J Small Anim Pract 2005;46:139145.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 33

    DeFrancesco TC, Atkins CE, Keene BW, et al. Prospective clinical evaluation of serum cardiac troponin T in dogs admitted to a veterinary teaching hospital. J Vet Intern Med 2002;16:553557.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 34

    Bonagura JB, Luis Fuentes V. Echocardiography. In:Ettinger SJ, Feldman EC, ed.Textbook of veterinary internal medicine. Philadelphia: WB Saunders Co, 2000;834873.

    • Search Google Scholar
    • Export Citation
  • 35

    Meurs KM, Spier AW, Wright NA, et al. Use of the ambulatory electrocardiogram for detection of ventricular premature complexes in healthy dogs. J Am Vet Med Assoc 2001;218:12911295.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 36

    Sato Y, Kita T, Takatsu Y, et al. Biochemical markers of myocyte injury in heart failure. Heart 2004;90:11101113.

Advertisement